Glide Technology News Today

Ladies, let’s talk about a common beauty challenge we all face – unwanted facial hair. It’s the pesky intruder that refuses to leave, often forcing us into an endless cycle of plucking, waxing, or threading. But what if there was a way to bid farewell to the tyranny of facial hair conveniently and with lasting results? Enter Pluxy, the epilator that promises to be your best friend in the quest for silky, hair-free skin.

Cooper’s newest tire design offers CUV, SUV, and truck owners an ideal tire for adventures. Here’s why its timing is ideal.

Wet n Wild Emerald Pointe Celebrates 40th Birthday with Splash-Tastic Season Pass Offer

The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

The action follows an FDA letter to professionals in February warning of a potential for structural failure.

The Food and Drug Administration has issued a safety alert regarding the potential risk of early structural valve deterioration with Abbott Trifecta valves.

Some evidence suggests early structural valve deterioration is more common with these valves than others on the market.

Abbott and the FDA are telling health providers that the company's Trifecta family of heart valves could deteriorate early. 

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is withdrawing...